ArticleMolecular diversity2026
Rational design of triazole tyrosinase inhibitors via integrated free energy calculations.
Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tyrosinase (TYR) is a copper-containing metalloenzyme involved in melanin biosynthesis and is an important target in the development of treatments for hyperpigmentation disorders, including melasma, post-inflammatory hyperpigmentation, and melanoma. Among the scaffold classes investigated for TYR inhibition, 1,2,4-triazole derivatives have attracted increasing interest. In this study, we evaluated a structurally diverse series of triazole derivatives using an integrated computational workflow that included absorption, distribution, metabolism, excretion and toxicity (ADMET) profiling, molecular docking, molecular dynamics (MD) simulations, and binding free energy calculations based on Linear Interaction Energy (LIE) and Free Energy Perturbation (FEP). Using Bacillus megaterium TYR as the model enzyme, the triazole derivatives generally produced more favorable docking scores than kojic acid and established recurring interactions with hydrophobic residues such as Met215, Val217, Ala221, and Phe227, as well as hydrogen-bonding contacts with Gly216. The free energy calculations reproduced the experimental binding affinities with high accuracy (FEP: R² = 0.91, MAE = 0.20 kcal/mol; LIE: R² = 0.93, MAE = 0.54 kcal/mol). Residue-level energy analysis indicated that interactions involving Arg209, Gly216 and Val218 play a major role in ligand binding across the series, with aromatic and halogenated substituents favoring stronger van der Waals contacts in this region. Overall, these results provide a consistent structural and energetic framework for understanding triazole-based TYR inhibition and may support the rational design of improved inhibitors for cosmetic and therapeutic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.